Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B — Beverly L. Falcón (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B
Shared by
Douglas Hanahan
Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B
Article
2011
en
Authors
+4 more
BF
Beverly L. Falcón
KP
Kristian Pietras
JC
Jeyling Chou
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2007
Starch-Based Microparticles as Vehicles for the Delivery of Active Platelet-Derived Growth Factor
Gabriela A. Silva
,
O. P. Coutinho
,
Paul Ducheyne
,
Irving M. Shapiro
,
Rui L Reis
Article
2012
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
Luana Schito
,
Sergio Rey
,
Marco Tafani
,
Huafeng Zhang
,
Carmen Chak‐Lui Wong
,
Andrea Russo
,
Matteo Antonio Russo
,
Gregg L. Friedman
Article
2015
P0427 : Platelet-derived growth factor-D intensifies fibrogenesis through upregulation of TIMP-1 and signaling via both platelet-derived growth factor receptor type alpha and beta
Erawan Borkham‐Kamphorst
,
Steffen K. Meurer
,
Eddy Van de Leur
,
Ute Haas
,
Lidia Tihaa
,
Ralf Weiskirchen
Article
2015
Platelet-derived growth factor-D intensifies fibrogenesis through upregulation of TIMP-1 expression and signalling through both platelet-derived growth factor receptors type α and β
Erawan Borkham‐Kamphorst
,
Eddy Van de Leur
,
Ute Haas
,
Lidia Tihaa
,
SK Meurer
,
Ralf Weiskirchen
Article
1999
Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
Jeremy Grunstein
,
W. Gregory Roberts
,
Odile Mathieu‐Costello
,
Douglas Hanahan
,
Randall S. Johnson
Discussion(0)
No comments yet. Be the first to comment.